Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Is pre-biopsy MRI cost-effective relative to usual care in the diagnosis of prostate cancer?

Principal Investigator
Name
Trisha Saini
Degrees
B.S., M.S.
Institution
Weill Cornell Medical College
Position Title
Student
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-466
Initial CDAS Request Approval
Apr 4, 2019
Title
Is pre-biopsy MRI cost-effective relative to usual care in the diagnosis of prostate cancer?
Summary
We are conducting a study to determine if pre-biopsy MRI is cost-effective relative to usual care (systematic biopsy) in the diagnosis of prostate cancer. The inputs from this data set will help us understand what the patient trajectory looks like over time using usual care compared to MRI to diagnose and treat prostate cancer.
Aims

This study aims to determine if MRI guided biospy is cost-effective compared to usual care.

Collaborators

Rachael Collins
Ludolph Guichard